Travere Therapeutics, Inc. TVTX Operating margin

Operating margin at other companies

Vertex PharmaceuticalsVRTX

38%—

Eton Pharmaceuticals, Inc.ETON

-15.1%—

Viridian Therapeutics, Inc.VRDN

-569.7%-284pp

ANI PharmaceuticalsANIP

15.4%—

Zevra Therapeutics, Inc.ZVRA

-103.9%-43.0pp

BioCryst PharmaceuticalsBCRX

-33.3%-43.0pp

FAQ

What is Travere Therapeutics, Inc.'s operating margin?

Travere Therapeutics, Inc. (TVTX) reported operating margin of -10.6% in Q1 2026.

How has Travere Therapeutics, Inc.'s operating margin changed year-over-year?

Travere Therapeutics, Inc.'s operating margin increased by 87.2% year-over-year, from -83.1% to -10.6%.

What is the long-term trend for Travere Therapeutics, Inc.'s operating margin?

Over 4 years (2020 to 2025), Travere Therapeutics, Inc.'s operating margin has grown at a -38.4% compound annual growth rate (CAGR), from -88.8% to -12.8%.

What does operating margin mean?

Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.